Joint Trio Tablet is a combination pharmaceutical formulation containing Diacerein 50 mg, Glucosamine Sulfate Potassium Chloride 750 mg, and Methyl Sulfonyl Methane (MSM) 250 mg, designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta, thereby reducing cartilage degradation and promoting joint function. Glucosamine Sulfate Potassium Chloride serves as a key substrate for the biosynthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, contributing to cartilage repair and maintenance. Methyl Sulfonyl Methane is a naturally occurring organosulfur compound that provides sulfur necessary for the synthesis of connective tissue and exhibits antioxidant and anti-inflammatory effects, which may help reduce joint pain and improve mobility. The synergistic action of these active ingredients aims to reduce joint stiffness, pain, and inflammation while enhancing cartilage regeneration and overall joint health. Joint Trio Tablet is indicated for patients with mild to moderate osteoarthritis and other joint-related conditions requiring symptomatic relief and structural support. It should be used under medical supervision, with consideration of contraindications and potential drug interactions.